Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value

$0.82−0.06 (-6.69%)

Close on Nov 13, 2026Market cap $36.32MP/E –Yield –

Elutia EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Elutia's EPS for the twelve months ending Sep 30, 2024 was -$2.61. For fiscal 2025 it was $0.87. The highest annual figure on record is $0.87 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$0.87	–
FY2024	Dec 31, 2024	-$1.86	–
FY2023	Dec 31, 2023	-$2.07	–
FY2022	Dec 31, 2022	-$2.38	–
FY2021	Dec 31, 2021	-$2.38	–
FY2020	Dec 31, 2020	-$8.88	–
FY2019	Dec 31, 2019	-$18.48	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.04	–
Q2 FY2026	Jun 30, 2026	-$0.17	–
Q1 FY2026	Mar 31, 2026	-$0.17	–
Q3 FY2025	Sep 30, 2025	-$0.19	–
Q2 FY2025	Jun 30, 2025	-$0.26	–
Q1 FY2025	Mar 31, 2025	-$0.21	–
Q3 FY2024	Sep 30, 2024	-$0.33	–
Q2 FY2024	Jun 30, 2024	-$1.13	–
Q1 FY2024	Mar 31, 2024	-$0.75	–
Q4 FY2023	Dec 31, 2023	-$0.40	–
Q3 FY2023	Sep 30, 2023	-$0.57	–
Q2 FY2023	Jun 30, 2023	-$0.65	–
Q1 FY2023	Mar 31, 2023	-$0.49	–
Q2 FY2022	Jun 30, 2022	-$0.69	–
Q1 FY2022	Mar 31, 2022	-$0.60	–
Q4 FY2021	Dec 31, 2021	-$0.82	–
Q3 FY2021	Sep 30, 2021	-$0.81	–
Q2 FY2021	Jun 30, 2021	-$0.23	–
Q1 FY2021	Mar 31, 2021	-$0.50	–
Q3 FY2020	Sep 30, 2020	-$15.79	–
Q2 FY2020	Jun 30, 2020	-$7.99	–
Q1 FY2020	Mar 31, 2020	-$7.03	–
Q4 FY2019	Dec 31, 2019	-$4.29	–
Q3 FY2019	Sep 30, 2019	-$4.81	–